Momentis Surgical

Company Overview

Snapshot

Founded in August 2012 by Nir Shvalb, Momentis Surgical operates with 51–200 employees. The company has raised a total of $128.45M across 7 funding rounds from 7 investors. In November 2024, Momentis Surgical received FDA 510(k) clearance for its second-generation Anovo robotic platform, which introduces haptic feedback and dual-mode articulation.

Business overview

Momentis Surgical is dedicated to transforming robot-assisted surgery through its proprietary technology. The company's Anovo Surgical System features humanoid-shaped miniature robotic arms designed for high dexterity, superhuman flexibility, and 360-degree articulation, enabling exceptional access and maneuverability. This system is intended to assist in the accurate control of the Anovo Arms during single-site, natural orifice laparoscopic-assisted transvaginal benign surgical procedures. Momentis Surgical serves the healthcare industry, specifically targeting hospitals and ambulatory surgery centers with a cost-effective and smaller-footprint robotic system compared to conventional alternatives. The company operates within the Health Tech & Life Sciences sector, focusing on medical devices, medical treatment, and therapeutics, with a core technology in machinery and robotics.

Strategic signal

Momentis Surgical received FDA 510(k) clearance for its second-generation Anovo robotic platform in November 2024, integrating haptic feedback and dual-mode articulation. This development is significant as it enhances the precision and control offered by the Anovo system, potentially broadening its applicability and improving surgical outcomes. For investors, this signals continued product innovation and regulatory validation, reinforcing the company's competitive position in the rapidly evolving robotic-assisted surgery market.

Company Intelligence Q&A

What was a significant recent regulatory achievement for Momentis Surgical?

In November 2024, Momentis Surgical received FDA 510(k) clearance for its second-generation Anovo robotic platform, which introduces haptic feedback and dual-mode articulation.

When did Momentis Surgical expand its Anovo robotic system into the general surgery market?

In October 2024, Momentis Surgical expanded into the general surgery market with FDA 510(k) clearance for its Anovo robotic system.

Which hospitals adopted the Anovo Surgical System in late 2022?

In November 2022, Medical City Plano in Texas adopted the Anovo Surgical System. In October 2022, HCA Florida Northwest Hospital also acquired the system.

What was a key operational challenge faced by Momentis Surgical in 2023?

In May 2023, Momentis Surgical underwent a team reduction, cutting 60% of its staff, approximately one year after a $1 billion SPAC deal fell through.

When did Momentis Surgical rebrand from Memic Innovative Surgery?

In July 2022, Memic Innovative Surgery announced its rebrand to Momentis Surgical to reflect a corporate transformation.